long-term outcomes following car t cell therapy: w：CAR
CAR
Long
https://www.nature.com
The most common long-term adverse effects observed thus far are B cell depletion (aplasia), hypogammaglobulinaemia, cytopenias and infections ( ...
Long
https://pubmed.ncbi.nlm.nih.go
In this Review, we summarize long-term follow-up data on efficacy and toxicities from patients treated with CAR T cells targeting CD19 or BCMA.
Long-term outcomes following CAR T
https://lymphomahub.com
Overall, long-term data demonstrate the high efficacy and minimal levels of toxicity associated with BCMA/CD19-targeted CAR T-cell therapy in hematological ...
Long
https://www.sciencedirect.com
Overall survival in all subjects receiving a flu/cy regimen was 13.3 months with a 34.7% probability of survival beginning at 38 months (mF/U 18.7 months), ...
Long
https://ashpublications.org
Of 51 ALL patients, 31 (60.8%) achieved a complete response (CR) with 28/31 (90%) of responders negative for minimal residual disease (MRD-).